Menu
Back to User profile » Dr Song Wen
Papers published by Dr Song Wen:
The Barriers to Insulin Therapy Initiation in Type 2 Diabetes Patients: A Study of General Practitioner Perceptions in Huinan Community in South Shanghai
Wen S, Ruan Y, Shi Z, Dan S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:393-405
Published Date: 24 January 2024
The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot
Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C, Yuan X, Jin J, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3197-3211
Published Date: 17 October 2023
The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease
Qiao C, Gu C, Wen S, He Y, Yang S, Feng X, Zeng Y
Hepatic Medicine: Evidence and Research 2023, 15:165-183
Published Date: 6 October 2023
Effect of Intestinal Flora on Hyperuricemia-Induced Chronic Kidney Injury in Type 2 Diabetic Patients and the Therapeutic Mechanism of New Anti-Diabetic Prescription Medications
Yan W, Wen S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3029-3044
Published Date: 29 September 2023
Splenic Infarction with Myocardial Injury in a Diabetic Patient: A Case Report
Wang C, Wen S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:2929-2937
Published Date: 22 September 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs
Huang X, Chen H, Wen S, Dong M, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1809-1819
Published Date: 21 June 2023
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1541-1554
Published Date: 30 May 2023
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance
Dong M, Chen H, Wen S, Yuan Y, Yang L, Li Y, Yuan X, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:425-435
Published Date: 14 February 2023
The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
Dong M, Chen H, Wen S, Yuan Y, Yang L, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:437-445
Published Date: 14 February 2023
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Dong M, Wen S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2583-2597
Published Date: 22 August 2022
Relationship Between Sporadic Renal Cysts and Renal Function Detected by Isotope Renography in Type 2 Diabetes
Li Y, Lou Q, Wen S, Zhou M, Xu D, Wang C, Liu X, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2443-2454
Published Date: 10 August 2022
A Pilot Study of Modified Mini-Clinical Evaluation Exercises (Mini-CEX) in Rotation Students in the Department of Endocrinology
He Y, Wen S, Zhou M, Li X, Gong M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2031-2038
Published Date: 9 July 2022
The Comparative Study on the Status of Bone Metabolism and Thyroid Function in Diabetic Patients with or without Ketosis or Ketoacidosis
Xu C, Gong M, Wen S, Zhou M, Li Y, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:779-797
Published Date: 12 March 2022
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
Wen S, Nguyen T, Gong M, Yuan X, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2955-2972
Published Date: 29 June 2021
Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes
Wen S, Liu C, Li Y, Pan J, Nguyen T, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2389-2397
Published Date: 26 May 2021
Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes
Liu C, Pan J, Wen S, Nguyen T, Xu D, Wang C, Yuan X, Wen Z, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:2349-2355
Published Date: 24 May 2021
Islet Autoantibodies in the Patients with Sjogren’s Syndrome and Thyroid Disease and Risk of Progression to Latent Autoimmune Diabetes in Adults: A Case Series
Wen S, Jiang W, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2021, 14:1025-1033
Published Date: 5 March 2021
Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2781-2799
Published Date: 5 August 2020
Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications
Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2020, 13:943-962
Published Date: 30 March 2020